Advertisement

European Journal of Dermatology

, Volume 28, Issue 3, pp 371–372 | Cite as

Multiple haemangiomas in TAFRO syndrome with atypical features of glomeruloid and epithelioid haemangiomas

  • Yoshiyuki Nakamura
  • Kazuma Iwamoto
  • Yasuhiro Fujisawa
  • Naoko Okiyama
  • Rei Watanabe
  • Yosuke Ishitsuka
  • Hiroshi Maruyama
  • Yoshiyuki Ishii
  • Yuya Kondo
  • Shingo Sakashita
  • Manabu Fujimoto
Correspondence

References

  1. 1.
    Jeunon T, Sampaio AL, Caminha RC, Reis CU, Dib C. Glomeruloidhemangioma in POEMS syndrome:a report on two cases and a review of the literature. An Bras Dermatol 2011; 86: 1167–73.CrossRefPubMedGoogle Scholar
  2. 2.
    Nara M, Komatsuda A, Itoh F, et al. Two cases of thrombocytopenia, anasarca, fever, reticulin fibrosis/renal failure, and organomegaly (TAFRO) syndrome with high serum procalcitonin levels, including the first case complicated with adrenal hemorrhaging. Intern Med 2017; 56: 1247–52.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Fajgenbaum DC, Rosenbach M, van Rhee F, Nasir A, Reutter J. Eruptive cherry hemangiomatosis associated with multicentric Castleman disease:a case report and diagnostic clue. JAMA Dermatol 2013; 149: 204–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Kishimoto S, Takenaka H, Shibagaki R, Noda Y, Yamamoto M, Yasuno H. Glomeruloid hemangioma in POEMS syndrome shows two different immunophenotypic endothelial cells. J Cutan Pathol 2000; 27: 87–92.CrossRefPubMedGoogle Scholar
  5. 5.
    Sun ZJ, Zhang L, Zhang WF, Alsharif MJ, Chen XM, Zhao YF. Epithelioid hemangioma in the oral mucosa:a clinicopathological study of seven cases and review of the literature. Oral Oncol 2006; 42: 441–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Chung WK, Lee DW, Yang JH, Lee MW, Choi JH, Moon KC. Glomeruloid hemangioma as a very early presenting sign of POEMS syndrome. J Cutan Pathol 2009; 36: 1126–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Chan PT, Lee KC, Chong LY, Lo KK, Cheung YF. Glomeruloid haemangioma with cerebriform morphology in a patient with POEMS syndrome. Clin Exp Dermatol 2006; 31: 775–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Masaki Y, Kawabata H, Takai K, et al. Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version. Int J Hematol 2016; 103: 686–92.CrossRefPubMedGoogle Scholar
  9. 9.
    Iwaki N, Fajgenbaum DC, Nabel CS, et al. Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV–8–negative multicentric Castleman disease. Am J Hematol 2016; 91: 220–6.CrossRefPubMedGoogle Scholar
  10. 10.
    Middleton K, Jones J, Lwin Z, Coward JI. Interleukin–6:an angiogenic target in solid tumours. Crit Rev Oncol Hematol 2014; 89: 129–39.CrossRefPubMedGoogle Scholar

Copyright information

© John Libbey Eurotext 2018

Authors and Affiliations

  • Yoshiyuki Nakamura
    • 1
  • Kazuma Iwamoto
    • 1
  • Yasuhiro Fujisawa
    • 1
  • Naoko Okiyama
    • 1
  • Rei Watanabe
    • 1
  • Yosuke Ishitsuka
    • 1
  • Hiroshi Maruyama
    • 1
  • Yoshiyuki Ishii
    • 1
  • Yuya Kondo
    • 2
  • Shingo Sakashita
    • 3
  • Manabu Fujimoto
    • 1
  1. 1.Department of Dermatology, Faculty of MedicineUniversity of TsukubaTsukuba, IbarakiJapan
  2. 2.Division of Clinical Immunology, Doctoral Program of Clinical Sciences, Graduate School of Comprehensive Human ScienceUniversity of TsukubaTsukuba, IbarakiJapan
  3. 3.Department of Diagnostic Pathology, Faculty of MedicineUniversity of TsukubaTsukuba, IbarakiJapan

Personalised recommendations